← All stocks

MAIA Biotechnology, Inc.

MAIA Net buying
CIK 0001878313 #4432 in the set updated 17 Sep 2026
Bought (12 mo)
$1.01M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$1.01M
+$1.01M against sales at will

By person

7 insiders · 28 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Vitoc Vlad
Chief Executive Officer
$302.44K (7)
+$302.44K
1,259,221
$1.73M
+23.5%
Guerrero Ramiro
Director
$252.31K (6)
+$252.31K
773,296
$1.06M
+142.0%
Smith Stan
Director
$251.82K (9)
+$251.82K
1,519,178
$2.08M
+49.8%
Louie Ngar Yee
Director
$100.00K (1)
+$100.00K
1,248,888
$1.71M
+7.0%
Luput Cristian
Director
$51.63K (3)
+$51.63K
437,628
$599.55K
+19.1%
CHAOUKI STEVEN M
Director
$50.00K (1)
+$50.00K
151,873
$208.07K
+70.9%
Gryaznov Sergei
Chief Scientific Officer
$2.69K (1)
+$2.69K
46,511
$63.72K
+4.5%

No percentages here. This company's share count has moved by a factor of 2.4 over the window, from 25,332,069 to 60,825,844 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 51
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 2 Aug 2022